The landscape of diabetes care is evolving with the arrival of transdermal GLP-1 delivery . These innovative devices offer a possibly more comfortable alternative to needle administrations for individuals living with type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the skin , circumventing the necessity for daily injections